{"id":"W2169012257","doi":"10.1016/s1470-2045(15)70056-2","title":"Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":220,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Medical Association; University of Alberta","funders":"Merck","keywords":"Vorinostat; Tolerability; Medicine; Internal medicine; Placebo; Population; Oncology; Adverse effect; Surgery; Histone deacetylase; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009663969,0.00153796,0.002753304,0.0003203871,0.0003181557,0.0009527721,0.0008051973,0.001423909,0.0053411],"category_scores_gemma":[0.001085733,0.0006381445,0.002178776,0.000475096,0.0008772443,0.001012541,0.0003279433,0.002689387,0.0007845964],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006402612,"about_ca_system_score_gemma":0.000663341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001290282,"about_ca_topic_score_gemma":0.002960477,"domain_scores_codex":[0.9997332,0.0001202775,0.00002039645,0.00005278592,0.00002062471,0.0000527746],"domain_scores_gemma":[0.999613,0.00009920002,0.00008304637,0.00002805413,0.00002871498,0.0001480391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9630018,0.003191147,0.0007298766,0.001467362,0.001879412,0.00006746033,0.00006359579,0.000403994,0.005133839,0.0001445026,0.001291464,0.0226255],"study_design_scores_gemma":[0.9498705,0.04648554,0.001526595,0.00004260879,0.0005756696,0.00003909126,0.00003100231,0.0002672889,0.0003293151,0.0001237822,0.0006939889,0.00001470348],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808108,0.01081174,0.0006195403,0.0009363683,0.001111334,0.001912864,0.001266917,0.0001674718,0.002362987],"genre_scores_gemma":[0.9822118,0.007614173,0.0009533281,0.001164594,0.0004406375,0.001481296,0.00149618,0.0000262747,0.00461181],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0053411,"threshold_uncertainty_score":0.0178678,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03588223247442272,"score_gpt":0.360391855471871,"score_spread":0.3245096229974483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}